Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-021-01663-9, published online 15 December 2021
The article "Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer ", written by Peter H. J. Slootbeek, Iris S. H. Kloots, Minke Smits, Inge M. Oort, Winald R. Gerritsen, Jack A. Schalken, Marjolijn J. L. Ligtenberg, Katrien Grünberg, Leonie I. Kroeze, Haiko J. Bloemendal, Niven Mehra, was originally published electronically on the publisher’s internet portal on 15 December 2021 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 13 January 2022 to © The Author(s) 2022 and the article is forthwith distributed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Slootbeek, P.H.J., Kloots, I.S.H., Smits, M. et al. Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer. Br J Cancer 126, 1108 (2022). https://doi.org/10.1038/s41416-022-01765-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-022-01765-y